These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

743 related items for PubMed ID: 18577435

  • 1. The surface characterisation and comparison of two potential sub-micron, sugar bulking excipients for use in low-dose, suspension formulations in metered dose inhalers.
    James J, Crean B, Davies M, Toon R, Jinks P, Roberts CJ.
    Int J Pharm; 2008 Sep 01; 361(1-2):209-21. PubMed ID: 18577435
    [Abstract] [Full Text] [Related]

  • 2. Particulate drug interactions with polymeric and elastomeric valve components in suspension formulations for metered dose inhalers.
    James J, Davies M, Toon R, Jinks P, Roberts CJ.
    Int J Pharm; 2009 Jan 21; 366(1-2):124-32. PubMed ID: 18835343
    [Abstract] [Full Text] [Related]

  • 3. An assessment of beclomethasone dipropionate clathrate formation in a model suspension metered dose inhaler.
    Bouhroum A, Burley JC, Champness NR, Toon RC, Jinks PA, Williams PM, Roberts CJ.
    Int J Pharm; 2010 May 31; 391(1-2):98-106. PubMed ID: 20184946
    [Abstract] [Full Text] [Related]

  • 4. Formulation of a novel fixed dose combination of salmeterol xinafoate and mometasone furoate for inhaled drug delivery.
    Liu S, Watts AB, Du J, Bui A, Hengsawas S, Peters JI, Williams RO.
    Eur J Pharm Biopharm; 2015 Oct 31; 96():132-42. PubMed ID: 26220015
    [Abstract] [Full Text] [Related]

  • 5. In vitro investigation of drug particulates interactions and aerosol performance of pressurised metered dose inhalers.
    Traini D, Young PM, Rogueda P, Price R.
    Pharm Res; 2007 Jan 31; 24(1):125-35. PubMed ID: 17103336
    [Abstract] [Full Text] [Related]

  • 6. Influence of crystal form of ipratropium bromide on micronisation and aerosolisation behaviour in dry powder inhaler formulations.
    Shur J, Kubavat HA, Ruecroft G, Hipkiss D, Price R.
    J Pharm Pharmacol; 2012 Sep 31; 64(9):1326-36. PubMed ID: 22881444
    [Abstract] [Full Text] [Related]

  • 7. Physicochemical and in vitro deposition properties of salbutamol sulphate/ipratropium bromide and salbutamol sulphate/excipient spray dried mixtures for use in dry powder inhalers.
    Corrigan DO, Corrigan OI, Healy AM.
    Int J Pharm; 2006 Sep 28; 322(1-2):22-30. PubMed ID: 16815654
    [Abstract] [Full Text] [Related]

  • 8. Comparative study of erythritol and lactose monohydrate as carriers for inhalation: atomic force microscopy and in vitro correlation.
    Traini D, Young PM, Jones M, Edge S, Price R.
    Eur J Pharm Sci; 2006 Feb 28; 27(2-3):243-51. PubMed ID: 16330191
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of highly branched cyclic dextrin in inhalable particles of combined antibiotics for the pulmonary delivery of anti-tuberculosis drugs.
    Kadota K, Senda A, Tagishi H, Ayorinde JO, Tozuka Y.
    Int J Pharm; 2017 Jan 30; 517(1-2):8-18. PubMed ID: 27913241
    [Abstract] [Full Text] [Related]

  • 10. Influence of primary crystallisation conditions on the mechanical and interfacial properties of micronised budesonide for dry powder inhalation.
    Kubavat HA, Shur J, Ruecroft G, Hipkiss D, Price R.
    Int J Pharm; 2012 Jul 01; 430(1-2):26-33. PubMed ID: 22449413
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of milling and sieving on functionality of dry powder inhalation products.
    Steckel H, Markefka P, teWierik H, Kammelar R.
    Int J Pharm; 2006 Feb 17; 309(1-2):51-9. PubMed ID: 16377105
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Formulation pre-screening of inhalation powders using computational atom-atom systematic search method.
    Ramachandran V, Murnane D, Hammond RB, Pickering J, Roberts KJ, Soufian M, Forbes B, Jaffari S, Martin GP, Collins E, Pencheva K.
    Mol Pharm; 2015 Jan 05; 12(1):18-33. PubMed ID: 25380027
    [Abstract] [Full Text] [Related]

  • 18. Characterisation and functionality of inhalation anhydrous lactose.
    Pitchayajittipong C, Price R, Shur J, Kaerger JS, Edge S.
    Int J Pharm; 2010 May 10; 390(2):134-41. PubMed ID: 20100552
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.